Intrabody strategies for the treatment of human papillomavirus-associated disease (Q36810292)

16 August 2017

1 reference

title

Intrabody strategies for the treatment of human papillomavirus-associated disease (English)

1 reference

16 August 2017

main subject

human papilloma virus

1 reference

human papillomavirus

29 September 2024

2

Heather Griffin

1 reference

16 August 2017

John Doorbar

1

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

Expert Opinion on Biological Therapy

16 August 2017

published in

1 reference

16 August 2017

volume

7

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

677-689

1 reference

In vivo disruption of the cytokeratin cytoskeleton in cultured epithelial cells by microinjection of antikeratin: evidence for the presence of an intermediate-filament-organizing center.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Antigen-independent selection of stable intracellular single-chain antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Selection of antibodies for intracellular function using a two-hybrid in vivo system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

beta-site specific intrabodies to decrease and prevent generation of Alzheimer's Abeta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Intracellular antibodies against HIV-1 envelope protein for AIDS gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Characterization of anti-cyclin E single-chain Fv antibodies and intrabodies in breast cancer cells: enhanced intracellular stability of novel sFv-F(c) intrabodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Molecular biology of human papillomavirus infection and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Commentary: Systematic reviewers face challenges from varied study designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Therapy for genital human papillomavirus-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

The treatment of human papillomavirus lesions of the lower genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Juvenile recurrent respiratory papillomatosis: still a mystery disease with difficult management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Intracellular anti-E7 human antibodies in single-chain format inhibit proliferation of HPV16-positive cervical carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Inhibition of papillomavirus protein function in cervical cancer cells by intrabody targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Molecular Targets for Papillomavirus Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

The papillomavirus life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Papillomavirus E1 proteins: form, function, and features

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Stable replication of papillomavirus genomes in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Identification of cis-acting elements that mediate the replication and maintenance of human papillomavirus type 16 genomes in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

The selection of intracellular antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Human papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the papillomavirus life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Role of the E1--E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Human papillomavirus in cervical screening and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

The role of the E6-p53 interaction in the molecular pathogenesis of HPV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Advances in the development of therapeutic nucleic acids against cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

RNA interference for treating cancers caused by viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Viruses in therapy--royal road or dead end?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Gene therapy for cancer treatment: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Engineered nanoparticles as precise drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Knocking down disease with siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Protein transduction: cell penetrating peptides and their therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Induction of productive human papillomavirus type 11 life cycle in epithelial cells grown in organotypic raft cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

Life cycle heterogeneity in animal models of human papillomavirus-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.7.5.677

21 January 2018

Identifiers

DOI

10.1517/14712598.7.5.677

1 reference

release_ce5oq7fi7bhaxlkzzwynyjigvy

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ce5oq7fi7bhaxlkzzwynyjigvy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference